Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Romiplostim injection	TA221 - Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura
Ropivacaine 75mg/10ml injection
Rucaparib (Rubraca®)	TA611 - Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer
Salbutamol
Salicylic acid 10% w/w in emulsifying ointment		Unlicensed special
Salicylic acid 2% in white soft paraffin (100g)
Salicylic acid 2% w/w and sulphur 2% w/w in aqueous cream		Unlicensed special
Salicylic acid 2% w/w in emulsifying ointment		Unlicensed special
Salicylic acid 20% w/w in emulsifying ointment		Unlicensed specials
Salicylic acid 5% w/w / propylene glycol 47.5% w/w in Dermovate® cream		Unlicensed special

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.